<DOC>
	<DOCNO>NCT00159081</DOCNO>
	<brief_summary>Prospective , randomize , double-blind , multi-center study 1 year course treatment outcome low-dose typical ( haloperidol ) vs. atypical neuroleptic ( risperidone ) first-episode schizophrenia .</brief_summary>
	<brief_title>One Year Drug Treatment First-Episode Schizophrenia</brief_title>
	<detailed_description>The objective multi-center study optimize long-term treatment patient first episode schizophrenia . This investigation contribute issue effective relapse prevention first-episode patient . 1-year maintenance neuroleptic treatment do low dose haloperidol risperidone ( target dose 2-4 mg/die ) .</detailed_description>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Haloperidol</mesh_term>
	<mesh_term>Haloperidol decanoate</mesh_term>
	<mesh_term>Risperidone</mesh_term>
	<criteria>After acute treatment firstepisode schizophrenia ( accord ICD10 F20 ) Age 18 55 Informed consent Residence outside catchment area Legal reason Insufficient knowledge German language Substance abuse addiction Pregnancy Serious physical illness Organic brain disease Contraindication neuroleptic treatment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>January 2008</verification_date>
	<keyword>Schizophrenia</keyword>
	<keyword>first episode</keyword>
	<keyword>long-term treatment</keyword>
	<keyword>typical vs. atypical neuroleptic</keyword>
</DOC>